ABSTRACT Resistance training has shown the potential to contribute to better glycemic control in people with Type 1 Diabetes (T1D), however, there are contradictory results in this regard and a need to clarify the effects of isolated resistance training on glycemic control in T1D. The aim was to verify the effects of resistance training on the glycemic control of people with T1D. Original articles were selected, randomized and non-randomized clinical trials that aimed to verify chronic responses, through the concentrations of glycated hemoglobin (HbA1c), to a structured program of resistance exercise in the glycemia of patients with T1D. The following databases were searched; MEDLINE, PubMed, Web of Science, Scopus, ScienceDirect, LILACS, and SciELO. Five studies were included in the review. A reduction in HbA1c was observed (SMD = -0.568 ± 0.165 [95% CI = -0.891 to -0.246]; p = 0.001; I² = 82%) in patients undergoing resistance training, when compared to the control group (SMD = 1.006 ± 0.181 [95% CI = 0.653 to 1.360]; p <0.001). Two studies, with children and adolescents and longer interventions, demonstrated a significant reduction in HbA1c, increased strength, and an improved lipid profile. Resistance training was efficient for assisting in glycemic control in people with T1D and should be incorporated in treatment plans.

ABSTRACT Objective: To estimate the rate of change during exercise and during recovery in moderate-continuous exercise (MCE) and high-intensity intermittent exercise (HIIE) in children and adolescents with type 1 diabetes (T1D). Subjects and methods: Participants performed 2 sessions of exercise: thirty minutes of continuous activity on a cycle ergometer (60% of VO2max) and thirty minutes (60% VO2max) interspersed with five bouts of maximum intensity lasting ten seconds every five minutes. Capillary blood glucose was measured before and after each test. The glucose rate of change in exercise (RoCE) was calculated (final blood glucose – onset blood glucose/exercise time), and the glucose rate of change in recovery (RoCR) (blood glucose 30 minutes after exercise – end of exercise blood glucose/recovery time). Results: The study included thirty-one participants (aged 13 ± 1.88 years). A lower blood glucose reduction was observed in the HIIE group, as well as better recovery values before, after, and thirty minutes after the test, respectively (333.14 ± 69.53, 226.19 ± 68.05 and 201.77 ± 66.84 versus 211.36 ± 91.03, 155.98 ± 82,68 and 165.76 ± 72.94). Covariance analyses showed a significant difference in glycemic variation between continuous and intermittent protocols immediately after exercise (−2.90 versus −2.08) and during the recovery period (−0.677 versus −0.389). Conclusions: HIIE led to a lower glucose reduction rate per minute during exercise and better recovery in the first 30 minutes after exercise compared to MCE in children and adolescents with T1D.

RESUMO A Diabetes Mellitus Tipo 1 (DM1) é uma doença autoimune que afeta milhares de pessoas atualmente, com maior concentração de casos na adolescência. O tratamento implica alterações no estilo de vida que podem apresentar influência negativa sobre a qualidade do sono (QS) e qualidade de vida (QV). O propósito do estudo foi comparar a QS e QV entre adolescentes portadores e não portadores de DM1. Participaram do estudo 74 adolescentes divididos por grupos e sexo: GDM1-F (n=19), GDM1-M (n=18), GC-F (n=21) e GC-M (n=16). Os instrumentos utilizados foram o Índice de Qualidade do Sono de Pittsburgh e WHOQOL-bref. Para comparar os grupos foi utilizado Análise de Covariância, ajustada pela idade, com Post Hoc de Bonferroni. Os resultados sinalizam que os participantes do GDM1-F e GDM1-M, portadores de DM1, apresentaram maiores escores em todas as avaliações, com diferença significativa com o CG-F nas variáveis: QS global, Domínios Físico, Psicológico e Relações Sociais e QV total. Portanto, foi possível observar que os adolescentes portadores de DM1 apresentaram melhor avaliação da QS e QV em comparação as meninas sem DM1, independentemente da idade.

ABSTRACT Type 1 Diabetes Mellitus (DM1) is an autoimmune disease that affects thousands of people today, with a higher concentration of cases in adolescence. Treatment involves lifestyle changes that can have a negative influence on quality of sleep (QS) and quality of life (QL). The purpose of the study was to compare QS and QL among adolescents with and without DM1. Seventy-four adolescents participated in the study divided by groups and sex: GDM1-F (n=19), GDM1-M (n=18), GC-F (n=21) and GC-M (n=16). The instruments used were the Pittsburgh Sleep Quality Index and WHOQOL-bref. Age-adjusted Covariance Analysis with Bonferroni Post Hoc was used to compare the groups. The results show that the participants of GDM1-F and GDM1-M, with DM1, had higher scores in all evaluations, with significant difference with CG-F in the variables: global QS, Physical, Psychological and Social Relationships and total QL. Therefore, it was possible to observe that adolescents with DM1 had better QS and QL evaluations than girls without DM1, regardless of age.